Global Difluprednate Market Insights and Forecast to 2028

Difluprednate is a topical corticosteroid used for the symptomatic treatment of inflammation and pain associated with ocular surgery. It works by stopping the release of certain natural substances that cause swelling and pain.
Market Analysis and Insights: Global Difluprednate Market
Due to the COVID-19 pandemic, the global Difluprednate market size is estimated to be worth US$ 358.1 million in 2022 and is forecast to a readjusted size of US$ 824.1 million by 2028 with a CAGR of 14.9% during the review period. Fully considering the economic change by this health crisis, Patented Drug accounting for % of the Difluprednate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
Global key difluprednate manufacturers include Novartis, Ajanta Pharma etc.The top 1 company hold a share about 90%.North America is the largest market, with a share about 74%, followed by Europe and APAC with the share about 13% and 10%.
Global Difluprednate Scope and Segment
Difluprednate market is segmented by Type and by Sales Channel. Players, stakeholders, and other participants in the global Difluprednate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2017-2028.
Segment by Type
Patented Drug
Generic Drug
Segment by Sales Channel
Hospital
Drugs Store
Online
Others
By Company
Novartis
Ajanta Pharma
Sun Pharmaceutical
General Pharmaceuticals
Orchidia
Innovative Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions